Salud

Cantidad mínima de ticos enferma de gravedad luego de completar vacunación contra covid-19

Estudio revela que solo 0,08% de personas que recibieron las dos dosis han sido hospitalizados y 0,023% fallecieron. Autoridades sanitarias afirman que resultado confirma efectividad de innoculación

(FILES) In this file photo taken on January 26, 2021 A healthcare professional draws up a dose of the Oxford/AstraZeneca Covid-19 vaccine at the vaccination centre set up inside Brighton Centre in Brighton, southern England, on January 26, 2021. - The effectiveness of the Pfizer/BioNTech vaccine against Covid-19 declines faster than that of the AstraZeneca jab, according to a new study published on August 19, 2021. (Photo by Ben STANSALL / AFP)
(FILES) In this file photo taken on January 26, 2021 A healthcare professional draws up a dose of the Oxford/AstraZeneca Covid-19 vaccine at the vaccination centre set up inside Brighton Centre in Brighton, southern England, on January 26, 2021. - The effectiveness of the Pfizer/BioNTech vaccine against Covid-19 declines faster than that of the AstraZeneca jab, according to a new study published on August 19, 2021. (Photo by Ben STANSALL / AFP) BEN STANSALL
‌
‌

‌

‌
‌

‌

‌